<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39310091</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2057-1577</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Virus evolution</Title><ISOAbbreviation>Virus Evol</ISOAbbreviation></Journal><ArticleTitle>Deep mutational scanning of SARS-CoV-2 Omicron BA.2.86 and epistatic emergence of the KP.3 variant.</ArticleTitle><Pagination><StartPage>veae067</StartPage><MedlinePgn>veae067</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">veae067</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ve/veae067</ELocationID><Abstract><AbstractText>Deep mutational scanning experiments aid in the surveillance and forecasting of viral evolution by providing prospective measurements of mutational effects on viral traits, but epistatic shifts in the impacts of mutations can hinder viral forecasting when measurements were made in outdated strain backgrounds. Here, we report measurements of the impact of all single amino acid mutations on ACE2-binding affinity and protein folding and expression in the SARS-CoV-2 Omicron BA.2.86 spike receptor-binding domain. As with other SARS-CoV-2 variants, we find a plastic and evolvable basis for receptor binding, with many mutations at the ACE2 interface maintaining or even improving ACE2-binding affinity. Despite its large genetic divergence, mutational effects in BA.2.86 have not diverged greatly from those measured in its Omicron BA.2 ancestor. However, we do identify strong positive epistasis among subsequent mutations that have accrued in BA.2.86 descendants. Specifically, the Q493E mutation that decreased ACE2-binding affinity in all previous SARS-CoV-2 backgrounds is reversed in sign to enhance human ACE2-binding affinity when coupled with L455S and F456L in the currently emerging KP.3 variant. Our results point to a modest degree of epistatic drift in mutational effects during recent SARS-CoV-2 evolution but highlight how these small epistatic shifts can have important consequences for the emergence of new SARS-CoV-2 variants.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Ashley L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Utah School of Medicine, 15 N Medical Dr E, Salt Lake City, UT 84112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starr</LastName><ForeName>Tyler N</ForeName><Initials>TN</Initials><Identifier Source="ORCID">0000-0001-6713-6904</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, University of Utah School of Medicine, 15 N Medical Dr E, Salt Lake City, UT 84112, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virus Evol</MedlineTA><NlmUniqueID>101664675</NlmUniqueID><ISSNLinking>2057-1577</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2024 Jul 24:2024.07.23.604853. doi: 10.1101/2024.07.23.604853</RefSource><PMID Version="1">39091888</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">deep mutational scanning</Keyword><Keyword MajorTopicYN="N">epistasis</Keyword></KeywordList><CoiStatement>T.N.S. consults for Apriori Bio, Metaphore Biotechnologies, and Vir Biotechnology on deep mutational scanning. The lab of T.N.S. has received sponsored research agreements unrelated to the present work from Vir Biotechnology, Aerium Therapeutics, Inc., and Invivyd, Inc. T.N.S. may receive a share of intellectual property revenue as inventor on a Fred Hutchinson Cancer Center-optioned patent related to stabilization of SARS-CoV-2 RBDs.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39310091</ArticleId><ArticleId IdType="pmc">PMC11414647</ArticleId><ArticleId IdType="doi">10.1093/ve/veae067</ArticleId><ArticleId IdType="pii">veae067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adams RM, Mora T, Walczak AM. et al. Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves. eLife 2016;5:e23156. doi: 10.7554/eLife.23156</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.23156</ArticleId><ArticleId IdType="pmc">PMC5268739</ArticleId><ArticleId IdType="pubmed">28035901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Jian F, Wang J. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 2023;614:521–29. doi: 10.1038/s41586-022-05644-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05644-7</ArticleId><ArticleId IdType="pmc">PMC9931576</ArticleId><ArticleId IdType="pubmed">36535326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Wang J, Jian F. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 2022;602:657–63. doi: 10.1038/s41586-021-04385-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04385-3</ArticleId><ArticleId IdType="pmc">PMC8866119</ArticleId><ArticleId IdType="pubmed">35016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol 2023;21:162–77. doi: 10.1038/s41579-022-00841-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford KHD, Bloom JD. alignparse: A Python package for parsing complex features from high-throughput long-read sequencing. J Open Source Softw 2019;4:1915. doi: 10.21105/joss.01915</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01915</ArticleId><ArticleId IdType="pmc">PMC6939853</ArticleId><ArticleId IdType="pubmed">31897449</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadonaite B, Brown J, McMahon TE. et al. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades. Nature 2024;631:617–26. doi: 10.1038/s41586-024-07636-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07636-1</ArticleId><ArticleId IdType="pmc">PMC11254757</ArticleId><ArticleId IdType="pubmed">38961298</ArticleId></ArticleIdList></Reference><Reference><Citation>Delignette-Muller M, Dutang C. fitdistrplus: an R Package for fitting distributions. J Stat Softw Articles 2015;64:1–34.</Citation></Reference><Reference><Citation>Ellis D, Brunette N, Crawford KHD. et al. Stabilization of the SARS-CoV-2 spike receptor-binding domain using deep mutational scanning and structure-based design. Front Immunol 2021;12:710263. doi: 10.3389/fimmu.2021.710263</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.710263</ArticleId><ArticleId IdType="pmc">PMC8276696</ArticleId><ArticleId IdType="pubmed">34267764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler DM, Fields S. Deep mutational scanning: a new style of protein science. Nat Methods 2014;11:801–07. doi: 10.1038/nmeth.3027</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3027</ArticleId><ArticleId IdType="pmc">PMC4410700</ArticleId><ArticleId IdType="pubmed">25075907</ArticleId></ArticleIdList></Reference><Reference><Citation>Francino-Urdaniz IM, Steiner PJ, Kirby MB. et al. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening. Cell Rep 2021;36:109627. doi: 10.1016/j.celrep.2021.109627</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109627</ArticleId><ArticleId IdType="pmc">PMC8352667</ArticleId><ArticleId IdType="pubmed">34416153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietz RD, Schiestl RH. Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2007;2:38–41. doi: 10.1038/nprot.2007.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.15</ArticleId><ArticleId IdType="pubmed">17401336</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaney AJ, Starr TN, Bloom JD. An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain. Virus Evol 2022a;8:veac021. doi: 10.1093/ve/veac021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac021</ArticleId><ArticleId IdType="pmc">PMC9092643</ArticleId><ArticleId IdType="pubmed">35573973</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaney AJ, Starr TN, Eguia RT. et al. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy. PLoS Pathogens 2022b;18:e1010248. doi: 10.1371/journal.ppat.1010248</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010248</ArticleId><ArticleId IdType="pmc">PMC8856557</ArticleId><ArticleId IdType="pubmed">35134084</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaney AJ, Starr TN, Gilchuk P. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 2021;29:44–57.e9. doi: 10.1016/j.chom.2020.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC7676316</ArticleId><ArticleId IdType="pubmed">33259788</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian F, Feng L, Yang S. et al. Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding. PLoS Pathogens 2023;19:e1011868. doi: 10.1371/journal.ppat.1011868</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011868</ArticleId><ArticleId IdType="pmc">PMC10766189</ArticleId><ArticleId IdType="pubmed">38117863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian F, Wang J, Yisimayi A. et al. Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1. bioRxiv 2024. doi: 10.1101/2024.04.19.590276</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.04.19.590276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y, Uriu K, Okumura K. et al. Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant. bioRxiv 2024a. doi: 10.1101/2024.07.16.603835</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.07.16.603835</ArticleId><ArticleId IdType="pubmed">39159637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y, Yo MS, Tolentino JE. et al. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants. Lancet Infect Dis 2024b;24:e482–3. doi: 10.1016/S1473-3099(24)00415-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00415-8</ArticleId><ArticleId IdType="pubmed">38945150</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K, Lustig G, Römer C. et al. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant. Nat Commun 2023;14:8078. doi: 10.1038/s41467-023-43703-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43703-3</ArticleId><ArticleId IdType="pmc">PMC10700484</ArticleId><ArticleId IdType="pubmed">38057313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski JM, Parekh RN, Wittrup KD. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 1998;37:1264–73. doi: 10.1021/bi9722397</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi9722397</ArticleId><ArticleId IdType="pubmed">9477952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kugathasan R, Sukhova K, Moshe M. et al. Deep mutagenesis scanning using whole trimeric SARS-CoV-2 spike highlights the importance of NTD-RBD interactions in determining spike phenotype. PLoS Pathogens 2023;19:e1011545. doi: 10.1371/journal.ppat.1011545</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011545</ArticleId><ArticleId IdType="pmc">PMC10426949</ArticleId><ArticleId IdType="pubmed">37535672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Zhou D, Dijokaite-Guraliuc A. et al. A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity. Cell Rep Med 2024;5:101553. doi: 10.1016/j.xcrm.2024.101553</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2024.101553</ArticleId><ArticleId IdType="pmc">PMC11148769</ArticleId><ArticleId IdType="pubmed">38723626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W, Fu H, Jian F. et al. Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution. Nat Ecol Evol 2023;7:1457–66. doi: 10.1038/s41559-023-02123-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41559-023-02123-8</ArticleId><ArticleId IdType="pubmed">37443189</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher MC, Bartha I, Weaver S. et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci Trans Med 2022;14:eabk3445. doi: 10.1126/scitranslmed.abk3445</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abk3445</ArticleId><ArticleId IdType="pmc">PMC8939770</ArticleId><ArticleId IdType="pubmed">35014856</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulana A, Dupic T, Phillips AM. et al. Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1ʹ. Nat Commun 2022;13:7011. doi: 10.1038/s41467-022-34506-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34506-z</ArticleId><ArticleId IdType="pmc">PMC9668218</ArticleId><ArticleId IdType="pubmed">36384919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang WO, Tan TJC, Lei R. et al. Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning. Sci Adv 2022;8:eadd7221. doi: 10.1126/sciadv.add7221</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.add7221</ArticleId><ArticleId IdType="pmc">PMC9683733</ArticleId><ArticleId IdType="pubmed">36417523</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterman N, Levine E. Sort-seq under the hood: implications of design choices on large-scale characterization of sequence-function relations. BMC Genomics 2016;17:206. doi: 10.1186/s12864-016-2533-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-2533-5</ArticleId><ArticleId IdType="pmc">PMC4784318</ArticleId><ArticleId IdType="pubmed">26956374</ArticleId></ArticleIdList></Reference><Reference><Citation>Shusta EV, Kieke MC, Parke E. et al. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J Mol Biol 1999;292:949–56. doi: 10.1006/jmbi.1999.3130</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3130</ArticleId><ArticleId IdType="pubmed">10512694</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Addetia A. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19ʹ. Science 2021a;371:850–54. doi: 10.1126/science.abf9302</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf9302</ArticleId><ArticleId IdType="pmc">PMC7963219</ArticleId><ArticleId IdType="pubmed">33495308</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Dingens AS. et al. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. Cell Rep Med 2021b;2:100255. doi: 10.1016/j.xcrm.2021.100255</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100255</ArticleId><ArticleId IdType="pmc">PMC8020059</ArticleId><ArticleId IdType="pubmed">33842902</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Hannon WW. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 2022a;377:420–24. doi: 10.1126/science.abo7896</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo7896</ArticleId><ArticleId IdType="pmc">PMC9273037</ArticleId><ArticleId IdType="pubmed">35762884</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Hilton SK. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 Binding. Cell 2020;182:1295–310.e20. doi: 10.1016/j.cell.2020.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7418704</ArticleId><ArticleId IdType="pubmed">32841599</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Stewart CM. et al. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains. PLoS Pathogens 2022b;18:e1010951. doi: 10.1371/journal.ppat.1010951</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010951</ArticleId><ArticleId IdType="pmc">PMC9674177</ArticleId><ArticleId IdType="pubmed">36399443</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Thornton JW. Epistasis in protein evolution. Protein Sci 2016;25:1204–18. doi: 10.1002/pro.2897</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2897</ArticleId><ArticleId IdType="pmc">PMC4918427</ArticleId><ArticleId IdType="pubmed">26833806</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Zepeda SK, Walls AC. et al. ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Nature 2022c;603:913–18. doi: 10.1038/s41586-022-04464-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04464-z</ArticleId><ArticleId IdType="pmc">PMC8967715</ArticleId><ArticleId IdType="pubmed">35114688</ArticleId></ArticleIdList></Reference><Reference><Citation>Taft JM, Weber CR, Gao B. et al. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain. Cell 2022;185:4008–22.e14. doi: 10.1016/j.cell.2022.08.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.08.024</ArticleId><ArticleId IdType="pmc">PMC9428596</ArticleId><ArticleId IdType="pubmed">36150393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura T, Mizuma K, Nasser H. et al. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe 2024;32:170–80.e12. doi: 10.1016/j.chom.2024.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2024.01.001</ArticleId><ArticleId IdType="pubmed">38280382</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AL, Starr TN, Kosakovsky Pond SL. Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution. PLoS Pathogens 2023;19:e1011901. doi: 10.1371/journal.ppat.1011901</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011901</ArticleId><ArticleId IdType="pmc">PMC10783747</ArticleId><ArticleId IdType="pubmed">38157379</ArticleId></ArticleIdList></Reference><Reference><Citation>Toelzer C, Gupta K, Yadav SKN. et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science 2020;370:725–30. doi: 10.1126/science.abd3255</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3255</ArticleId><ArticleId IdType="pmc">PMC8050947</ArticleId><ArticleId IdType="pubmed">32958580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Guo Y, Liu L. et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature 2023;624:639–44. doi: 10.1038/s41586-023-06750-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06750-w</ArticleId><ArticleId IdType="pubmed">37871613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wentz AE, Shusta EV. A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins. Appl Environ Microbiol 2007;73:1189–98. doi: 10.1128/AEM.02427-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02427-06</ArticleId><ArticleId IdType="pmc">PMC1828678</ArticleId><ArticleId IdType="pubmed">17189442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Yu Y, Jian F. et al. Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86. Lancet Infect Dis 2023;23:e457–9. doi: 10.1016/S1473-3099(23)00573-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00573-X</ArticleId><ArticleId IdType="pubmed">37738994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Yu Y, Xu Y. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis 2024;24:e70–2. doi: 10.1016/S1473-3099(23)00744-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00744-2</ArticleId><ArticleId IdType="pubmed">38109919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahradník J, Marciano S, Shemesh M. et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol 2021;6:1188–98. doi: 10.1038/s41564-021-00954-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00954-4</ArticleId><ArticleId IdType="pubmed">34400835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Qiao S, Yu J. et al. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat Commun 2021;12:1607. doi: 10.1038/s41467-021-21767-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21767-3</ArticleId><ArticleId IdType="pmc">PMC7952905</ArticleId><ArticleId IdType="pubmed">33707453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>